Empfehlung
5,3
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
23.7
0 neu, 1 erhöht, 201K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Scholar Rock Holding Corp |
|---|---|
| Ticker | SRRK |
| CIK | 0001727196 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | 80706p103 |
|---|---|
| ISIN | US80706P1030 |
| Typ | Common Stock |
| Titel | Scholar Rock Holding Corp |
Status
| Zuletzt geprüft | 2026-03-20 22:34:32.383265 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| AMI ASSET MANAGEMENT CORP | 29,476 | 29,473 | 3 | 1,298,418 | Aufgestockt | 0,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | Marantz Jing L. | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -4,157 | 46.53 | -193,417.73 | -13,3% | |
| 2026-02-17 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -7,989 | 46.53 | -371,713.79 | -25,5% | |
| 2026-02-17 | Ho Junlin | Officer, GENERAL COUNSEL | Open Market Sale | -9,580 | 46.53 | -445,740.16 | -30,6% | |
| 2026-02-17 | Parlavecchio Caryn | Officer, CHRO | Open Market Sale | -9,035 | 46.53 | -420,382.29 | -28,9% | |
| 2026-01-22 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -12,779 | 46.85 | -598,748.54 | -41,1% | |
| 2026-01-22 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -2,119 | 45.87 | -97,188.99 | -6,7% | |
| 2026-01-16 | Ho Junlin | Officer, GENERAL COUNSEL | Open Market Sale | -8,016 | 44.48 | -356,533.24 | -24,5% | |
| 2026-01-16 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -8,406 | 44.48 | -373,879.55 | -25,7% | |
| 2026-01-16 | Parlavecchio Caryn | Officer, CHRO | Open Market Sale | -6,600 | 44.48 | -293,552.82 | -20,2% | |
| 2026-01-16 | Marantz Jing L. | Officer, CHIEF MEDICAL OFFICER | Open Market Sale | -5,798 | 44.48 | -257,881.70 | -17,7% | |
| 2026-01-14 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -13,112 | 45.20 | -592,611.26 | -40,7% | |
| 2026-01-13 | Woods Keith | Officer, Chief Operating Officer | Open Market Sale | -16,746 | 42.70 | -715,054.20 | -49,1% | |
| 2026-01-13 | Sinha Vikas | Officer, Chief Financial Officer | Open Market Sale | -16,755 | 42.70 | -715,438.50 | -49,1% | |
| 2026-01-13 | Sinha Vikas | Officer, Chief Financial Officer | Open Market Sale | -16,755 | 42.70 | -715,438.50 | -49,1% | |
| 2026-01-13 | Hallal David | Director, Officer, Chief Executive Officer | Open Market Sale | -57,450 | 42.70 | -2,453,115.00 | -168,5% | |
| 2026-01-13 | Hallal David | Director, Officer, Chief Executive Officer | Open Market Sale | -57,450 | 42.70 | -2,453,115.00 | -168,5% | |
| 2026-01-13 | Vaishnaw Akshay | Director, Officer, President of R&D | Open Market Sale | -20,438 | 42.70 | -872,702.60 | -59,9% | |
| 2025-12-16 | Peng Katie | Director | Open Market Sale | -726 | 43.88 | -31,854.05 | -2,2% | |
| 2025-12-16 | Peng Katie | Director | Open Market Sale | -280 | 44.63 | -12,497.63 | -0,9% | |
| 2025-12-04 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -136,462 | 45.21 | -6,169,788.18 | -423,7% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 4,403 | 40.97 | 180,390.91 | +12,4% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,400 | 40.18 | 498,232.00 | +34,2% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,796 | 39.31 | 503,010.76 | +34,5% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,796 | 39.31 | 503,010.76 | +34,5% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,400 | 40.18 | 498,232.00 | +34,2% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 4,403 | 40.97 | 180,390.91 | +12,4% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,796 | 39.31 | 503,010.76 | +34,5% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,400 | 40.18 | 498,232.00 | +34,2% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 4,403 | 40.97 | 180,390.91 | +12,4% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,796 | 39.31 | 503,010.76 | +34,5% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 12,400 | 40.18 | 498,232.00 | +34,2% | |
| 2025-10-07 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 4,403 | 40.97 | 180,390.91 | +12,4% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 18,414 | 37.89 | 697,706.46 | +47,9% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 13,748 | 39.52 | 543,320.96 | +37,3% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 13,748 | 39.52 | 543,320.96 | +37,3% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 80,863 | 38.68 | 3,127,780.84 | +214,8% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 18,414 | 37.89 | 697,706.46 | +47,9% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 80,863 | 38.68 | 3,127,780.84 | +214,8% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 80,863 | 38.68 | 3,127,780.84 | +214,8% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 13,748 | 39.52 | 543,320.96 | +37,3% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 80,863 | 38.68 | 3,127,780.84 | +214,8% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 18,414 | 37.89 | 697,706.46 | +47,9% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 18,414 | 37.89 | 697,706.46 | +47,9% | |
| 2025-10-06 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 13,748 | 39.52 | 543,320.96 | +37,3% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 56,703 | 36.74 | 2,083,268.22 | +143,1% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 56,703 | 36.74 | 2,083,268.22 | +143,1% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 11,011 | 35.61 | 392,101.71 | +26,9% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 319,700 | 37.42 | 11,963,174.00 | +821,5% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 56,703 | 36.74 | 2,083,268.22 | +143,1% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 11,011 | 35.61 | 392,101.71 | +26,9% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 319,700 | 37.42 | 11,963,174.00 | +821,5% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 319,700 | 37.42 | 11,963,174.00 | +821,5% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 11,011 | 35.61 | 392,101.71 | +26,9% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 11,011 | 35.61 | 392,101.71 | +26,9% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 56,703 | 36.74 | 2,083,268.22 | +143,1% | |
| 2025-10-03 | AKKARAJU SRINIVAS | Director | Open Market Purchase | 319,700 | 37.42 | 11,963,174.00 | +821,5% | |
| 2025-09-22 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -3,353 | 30.67 | -102,846.23 | -7,1% | |
| 2025-09-16 | Qatanani Mo | Officer, CHIEF SCIENTIFIC OFFICER | Open Market Sale | -3,178 | 33.52 | -106,526.56 | -7,3% | |
| 2025-09-16 | Peng Katie | Director | Open Market Sale | -930 | 32.48 | -30,202.77 | -2,1% | |
| 2025-09-16 | Peng Katie | Director | Open Market Sale | -76 | 33.20 | -2,522.92 | -0,2% | |
| 2025-05-29 | Vaishnaw Akshay | Director, Officer, President of R&D | Open Market Sale | -5,130 | 29.63 | -152,000.36 | -10,4% | |
| 2025-05-29 | Burow Kristina | Director | Open Market Sale | -1,000 | 29.24 | -29,241.90 | -2,0% | |
| 2025-05-29 | Reed Joshua | Director | Open Market Sale | -4,900 | 29.68 | -145,440.82 | -10,0% | |
| 2025-05-29 | Reed Joshua | Director | Open Market Sale | -500 | 30.04 | -15,021.75 | -1,0% | |
| 2025-05-29 | Reed Joshua | Director | Open Market Sale | -4,900 | 29.68 | -145,440.82 | -10,0% | |
| 2025-05-29 | Reed Joshua | Director | Open Market Sale | -500 | 30.04 | -15,021.75 | -1,0% | |
| 2025-05-29 | Vaishnaw Akshay | Director, Officer, President of R&D | Open Market Sale | -1,620 | 30.01 | -48,611.66 | -3,3% | |
| 2025-05-29 | Burow Kristina | Director | Open Market Sale | -4,400 | 29.83 | -131,268.72 | -9,0% |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| AMI ASSET MANAGEMENT CORP | 29,476 | 1,298,418 | 100.00 |